Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial (Q38983361)
Jump to navigation
Jump to search
scientific article published on 14 October 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial |
scientific article published on 14 October 2016 |
Statements
1 reference
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial (English)
1 reference
Bernadette Liegl-Atzwanger
0 references
Isabelle Ray-Coquard
1 reference
Stéphanie Clisant
1 reference
Nicolas Isambert
1 reference
François Bertucci
1 reference
Cécile Guillemet
1 reference
Christine Chevreau
1 reference
Emmanuelle Bompas
1 reference
Jennifer Wallet
1 reference
Sébastien Salas
1 reference
Christophe Perrin
1 reference
Corinne Delcambre
1 reference
Maud Toulmonde
1 reference
Sophie Taieb
1 reference
Olivier Collard
1 reference
Didier Cupissol
1 reference
Esma Saada-Bouzid
1 reference
Wolfgang Eisterer
1 reference
Loïc Chaigneau
1 reference
Thomas Brodowicz
1 reference
Antoine Italiano
1 reference
Sarah Dumont
1 reference
Maria Rios
1 reference
Laurence Bozec
1 reference
Christine Lemaignan
1 reference
14 October 2016
1 reference
1 reference
17
1 reference
12
1 reference
1732-1742
1 reference
Identifiers
1 reference
1 reference